Talarozole, which is effective in treatments of psoriasis and acne, inhibits selectivelyretinoic acid-metabolizing enzyme (CYP26A1) rather than CYP51 (sterol 14-demethylase) andCYP19 (aromatase)44). Here, CYP26A1 is linked to acne.